Health & Personal Care
HIGH
FDA DRUG
Glenmark Pharmaceuticals Recalls Viorele Tablets Over Impurity Issues
Glenmark Pharmaceuticals recalled 26,928 packs of Viorele oral contraceptives on September 3, 2025. The recall follows the discovery of impurity issues in the product. Consumers should stop using the affected tablets immediately and contact healthcare providers for guidance.
Viorele
Failed Impurities/Degradation